Response to: 'Successful treatment of plasma exchange for refractory systemic juvenile idiopathic arthritis complicated with macrophage activation syndrome and severe lung disease' by Sato et al

Ann Rheum Dis. 2022 Apr;81(4):e62. doi: 10.1136/annrheumdis-2020-217426. Epub 2020 Apr 21.

¹ Department of Pediatrics, Stanford University, Stanford, CA, USA mellins@stanford.edu vesaper@stanford.edu.
² Institute for Immunity, Transplantation and Infection, Center for Biomedical Informatics Research, Department of Medicine, Stanford University, Stanford, California, USA.
³ Department of Pediatric Radiology, Texas Children's Hospital, Houston, Texas, USA.
⁴ Department of Pediatrics, Division of Rheumatology, University of Alabama at Birmingham, Birmingham, Alabama, USA.
⁵ Department of Pediatrics, Program in Immunology, Stanford University, Stanford, CA, USA mellins@stanford.edu vesaper@stanford.edu.

No abstract available

Keywords: arthritis, juvenile; biologic therapy; cytokines; macrophagex; still's disease, adult-onset.

Publication types